advertiser banner advertiser banner advertiser banner
Digital Issues

Home >  News >  October, 2011

Propofol Makers Liable in Hepatitis C Outbreak Lawsuit

Teva, Baxter, McKesson ordered to pay infected patients $183.6 million.

Published: October 11, 2011

A Nevada jury has awarded 3 patients who contracted hepatitis C through hazardous practices at Las Vegas-area GI clinics $183.6 million in their lawsuit against the companies that supplied the clinics' propofol.

Manufacturer Teva Parenteral Medicines and distributors Baxter Healthcare and McKesson Medical-Surgical owe a combined $162.5 million in punitive and $20.1 million in compensatory damages to plaintiff patients Anne Arnold, Richard Sacks, Tony Devito and 2 of their spouses. Their lawsuit had argued that the companies' packaging of propofol in 50mL and 100mL vials without single-use-only warnings encouraged the clinics' staffs to reuse the drugs on multiple patients, spreading the disease.

"I think that sends a very loud message," the patients' attorney, Robert Eglet, told the Las Vegas Review-Journal. "Hopefully that will be enough for the drug companies to realize they need to come to this community, and they need to make this right and resolve this case with everyone. But if not, we're prepared to take you on."

Teva issued a statement announcing its plans to appeal the verdict. "Teva should not be held liable for the blatant disregard for patient safety by medical professionals at their facility," it read. "While the mistreatment of patients is unacceptable, it was not Teva's fault."

The Oct. 10 verdict wasn't the first multi-million dollar decision in the continuing litigation over the 2008 hepatitis C outbreak, the clinics' alleged negligence and the sedative at the center of the case. Last year, in the first trial to emerge from the incidents, Mr. Eglet represented patient Henry Chanin and his wife, whose lawsuit resulted in a $500 million award. (According to the Review-Journal, Mr. Eglet's legal team offered to settle the 3 patients' lawsuit for $4.9 million and the Chanins' for $1.7 million.) Plus, the newspaper notes, the jury in another case involving the outbreak and the drug makers has awarded patient Michael Washington and his wife $14 million in compensatory damages, with the punitive amount to come.

It's not likely to be the end of the litigation, either. Many more product liability lawsuits against the drugmakers await a trial date, and Dipak Desai, MD, the former owner of the Endoscopy Center of Southern Nevada, the clinics from which the outbreak began, has been ruled competent to stand trial alongside 2 nurses in a criminal prosecution.

David Bernard


Also in the News...

Daytime is Best for Lap Choles
Can We Predict the Quality of Recovery?
Patient Sues, But Facility, Physicians Not Liable for Tooth Loss
No One Noticed and No Alarms Sounded When Tourniquet Deflated
Medical Assistant Sues Anesthesia Group for Firing Her for Being Muslim
Train Surgeons and Staff on Electrosurgery Safety with FUSE
Patients Describe Their Anesthesia Awareness

 
Have an account? Please log in:
Email Address:
  Remember my login on this computer

DID YOU SEE THIS?
Medical Equipment

Mac Medical Can Meet All Your Standard or Customized Healthcare Equipment Needs

advertiser banner

Other Articles That May Interest You

Jackson Table Inventor Awarded $12.2M for Unpaid Royalties

Canadian Hospital Sued Over Improperly Cleaned Retractor

147 bariatric patients may have been exposed to bioburden on retractor.

Life Sentence for Hep C Outbreak Doc

Las Vegas gastroenterologist's CRNA co-defendant gets 7 to 21 years in prison.